A 5-YEAR FOLLOW-UP OF LOW-DENSITY-LIPOPROTEIN APHERESIS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA - A MULTICENTER STUDY

被引：0

作者：

YAMAMOTO, K

NAKASHIMA, Y

KOGA, N

SASAKI, J

TAKAGI, M

KOBORI, S

AGETA, M

HORI, H

ARIMA, S

TOMA, S

机构：

来源：

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES | 1995年 / 5卷 / 03期

关键词：

LIPOPROTEIN(A); LDL-CHOLESTEROL; LDL-APHERESIS; FAMILIAL HYPERCHOLESTEROLEMIA;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Saga Medical School, Saga; University of Occupational and Environmental Health, Kitakyushu; Koga Hospital, Kurume; School of Medicine, Fukuoka University, Fukuoka; School of Medicine, Nagasaki University, Nagasaki; Medical School, Kumamoto University, Kumamoto; Miyazaki Prefectural Nichinan Hospital, Nichinan; Beppu National Hospital, Beppu; Faculty of Medicine, Kagoshima University, Kagoshima; Naha Municipal Hospital, Naha

引用

页码：181 / 188

页数：8

共 50 条

[31] Italian Multicenter Study on Low-Density Lipoprotein Apheresis: Retrospective Analysis (2007)
Stefanutti, Claudia
THERAPEUTIC APHERESIS AND DIALYSIS, 2010, 14 (01) : 79 - 86
[32] Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS)
Nishimura, S
Sekiguchi, M
Kano, T
Ishiwata, S
Nagasaki, F
Nishide, T
Okimoto, T
Kutsumi, Y
Kuwabara, Y
Takatsu, F
Nishikawa, H
Daida, H
Yamaguchi, H
ATHEROSCLEROSIS, 1999, 144 (02) : 409 - 417
[33] IDENTIFICATION OF THE 664 PROLINE TO LEUCINE MUTATION IN THE LOW-DENSITY-LIPOPROTEIN RECEPTOR IN 4 UNRELATED PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE UK
KINGUNDERWOOD, L
GUDNASON, V
HUMPHRIES, S
SEED, M
PATEL, D
KNIGHT, B
SOUTAR, A
CLINICAL GENETICS, 1991, 40 (01) : 17 - 28
[34] Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-Lowering therapy
Vishwanath, Raghu
Hemphill, Linda C.
JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (01) : 18 - 28
[35] Efficacy of Evolocumab vs low-density lipoprotein cholesterol apheresis in patients with familial hypercholesterolemia and high cardiovascular risk (EVOLAFER01)
Torres, Esther
Goicoechea, Marian
Hernandez, Andres
Rodriguez Ferrero, Maria L.
Garcia, Ana
Macias, Nicolas
Anaya, Fernando
JOURNAL OF CLINICAL APHERESIS, 2020, 35 (01) : 9 - 17
[36] A case of sitosterolemia misdiagnosed as familial hypercholesterolemia: A 4-year follow-up
Wang, Wei
Jiang, Long
Chen, Pan-Pan
Wu, Yue
Su, Peng-Yu
Wang, Lu-Ya
JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (01) : 236 - 239
[37] THE EFFECT OF LDL APHERESIS ON PROGRESSION OF CORONARY-ARTERY-DISEASE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA - RESULTS OF A MULTICENTER LDL APHERESIS STUDY
WAIDNER, T
FRANZEN, D
VOELKER, W
RITTER, M
BORBERG, H
HOMBACH, V
HOPP, HW
CLINICAL INVESTIGATOR, 1994, 72 (11): : 858 - 863
[38] Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients
Visek, J.
Blaha, M.
Blaha, V
Lasticova, M.
Lanska, M.
Andrys, C.
Tebbens, J. Duintjer
Igreja e Sa, Ivone Cristina
Tripska, K.
Vicen, M.
Najmanova, I
Nachtigal, P.
ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
[39] Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a)
Schwarz, Andrea
Demuth, Ilja
Landmesser, Ulf
Haghikia, Arash
Konig, Maximilian
Steinhagen-Thiessen, Elisabeth
LIPIDS IN HEALTH AND DISEASE, 2022, 21 (01)
[40] Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a)
Andrea Schwarz
Ilja Demuth
Ulf Landmesser
Arash Haghikia
Maximilian König
Elisabeth Steinhagen-Thiessen
Lipids in Health and Disease, 21

← 1 2 3 4 5 →